AU2013234122A1 - Polypeptides and their use - Google Patents

Polypeptides and their use Download PDF

Info

Publication number
AU2013234122A1
AU2013234122A1 AU2013234122A AU2013234122A AU2013234122A1 AU 2013234122 A1 AU2013234122 A1 AU 2013234122A1 AU 2013234122 A AU2013234122 A AU 2013234122A AU 2013234122 A AU2013234122 A AU 2013234122A AU 2013234122 A1 AU2013234122 A1 AU 2013234122A1
Authority
AU
Australia
Prior art keywords
polypeptide
malassezia
product
infection
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013234122A
Other languages
English (en)
Inventor
Derry Mercer
Deborah O'neil
Colin Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NovaBiotics Ltd
Original Assignee
NovaBiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NovaBiotics Ltd filed Critical NovaBiotics Ltd
Publication of AU2013234122A1 publication Critical patent/AU2013234122A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polyamides (AREA)
  • Cosmetics (AREA)
AU2013234122A 2012-03-14 2013-03-14 Polypeptides and their use Abandoned AU2013234122A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1204457.4A GB201204457D0 (en) 2012-03-14 2012-03-14 Polypeptides and their use
GB1204457.4 2012-03-14
US201261620833P 2012-04-05 2012-04-05
US61/620,833 2012-04-05
PCT/GB2013/000112 WO2013136040A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use

Publications (1)

Publication Number Publication Date
AU2013234122A1 true AU2013234122A1 (en) 2014-10-16

Family

ID=46026493

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013234122A Abandoned AU2013234122A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use

Country Status (17)

Country Link
US (1) US20140155321A1 (https=)
EP (1) EP2825261A1 (https=)
JP (1) JP2015516943A (https=)
KR (1) KR20140138940A (https=)
CN (1) CN104428036A (https=)
AU (1) AU2013234122A1 (https=)
CA (1) CA2866837A1 (https=)
CL (1) CL2014002397A1 (https=)
GB (1) GB201204457D0 (https=)
HK (1) HK1201050A1 (https=)
IL (1) IL234646A0 (https=)
MX (1) MX2014010996A (https=)
NZ (1) NZ700467A (https=)
RU (1) RU2014139857A (https=)
SG (1) SG11201405539QA (https=)
WO (1) WO2013136040A1 (https=)
ZA (1) ZA201407276B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016244073B2 (en) * 2015-04-03 2019-02-28 Elc Management Llc Hair treatment compositions
JP6553961B2 (ja) * 2015-06-25 2019-07-31 花王株式会社 美白剤
WO2017047299A1 (ja) * 2015-09-15 2017-03-23 富士フイルム株式会社 注射用液剤組成物
CN109700834A (zh) * 2019-01-18 2019-05-03 上海市农业科学院 一种蛹虫草固体发酵物及其抗菌用途
AR122485A1 (es) * 2020-06-04 2022-09-14 Syngenta Crop Protection Ag Composiciones fungicidas
CN115381928B (zh) * 2022-10-27 2022-12-27 山东中医药大学附属医院 一种真菌提取物在制备溃疡性结肠炎治疗药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1927597B1 (en) * 2004-08-18 2016-11-02 Novabiotics Limited Antibacterial peptides
GB0611115D0 (en) * 2006-06-06 2006-07-19 Novabiotics Ltd Compounds and their use
GB0702022D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
RU2491052C2 (ru) * 2007-12-21 2013-08-27 Басф Се Противоперхотные композиции, содержащие пептиды

Also Published As

Publication number Publication date
NZ700467A (en) 2016-08-26
US20140155321A1 (en) 2014-06-05
IL234646A0 (en) 2014-11-30
ZA201407276B (en) 2015-06-24
MX2014010996A (es) 2014-10-13
EP2825261A1 (en) 2015-01-21
CN104428036A (zh) 2015-03-18
CA2866837A1 (en) 2013-09-19
CL2014002397A1 (es) 2015-02-27
JP2015516943A (ja) 2015-06-18
GB201204457D0 (en) 2012-04-25
HK1201050A1 (en) 2015-08-21
KR20140138940A (ko) 2014-12-04
WO2013136040A1 (en) 2013-09-19
SG11201405539QA (en) 2014-10-30
RU2014139857A (ru) 2016-05-10

Similar Documents

Publication Publication Date Title
AU2017283785A1 (en) Synergistic antifungal compositions and methods thereof
ES2729237T3 (es) Lipopéptidos antimicrobianos cortos
US8076484B2 (en) Modified green tea polyphenol formulations
US20140155321A1 (en) Polypeptides and Their Use
EP3124033A1 (en) Post-procedure wound healing skin care composition
EP2775838B1 (en) Aqueous antimicrobial composition containing coniferous resin acids
MX2011014006A (es) Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara.
CN110538313A (zh) 一种广谱抗马拉色菌的天然产物组合物及应用
JP2010517987A (ja) 塩基性ペプチド及びその複合型抗細菌−抗真菌剤としての使用
US20130131121A1 (en) Anti-viral agent
CN103957907A (zh) 抗真菌剂
KR101449129B1 (ko) Ａｂｈ 항원의 발현을 조절하는 물질을 포함하는 조성물
KR20070107806A (ko) 세르타코나졸, 및 하이드로코르티손 및/또는 항박테리아퀴놀린 화합물을 포함하는 항진균 조성물
KR20140119452A (ko) 멘톨 및 그 유사물질을 함유하는 피부 트러블 개선용 조성물
AU2019286511B2 (en) Enhancement of antibacterial actions of a depsipeptide antibiotic using synergistic amounts of boric acid
KR20110086466A (ko) 신규한 항생제 조성물 및 그람양성균의 치료 방법
JP7318082B2 (ja) 糖化ストレス抑制剤
RU2849609C1 (ru) Гель для наружного применения, обладающий адаптогенным действием
KR20250043943A (ko) 말라세지아 패치더마티스에 대한 항균 조성물
CA2479381C (en) A use of treatment for fungal infections with a synergistic formulation of antifungal agent, menthol and menthyl acetate
HK40060583A (en) Anti-fungal agent
CN113710248A (zh) 抗真菌剂
JP2022158120A (ja) 糖化ストレス抑制剤
HK1138773A (en) Anti-viral agent
RO128609A2 (ro) Forme farmaceutice destinate administrării locale, conţinând extracte atomizate de rosmarinus officinalis sp. şi hissopus officinalis sp.

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period